ABSTRACT. Cost-effectiveness studies often need to compare the cost of a program to the lifetime benefits of the program, but estimates of lifetime benefits are not routinely available, especially for older adults. We used data from two large longitudinal studies of older adults (ages 65-100) to estimate transition probabilities from one health state to another, and used those probabilities to estimate the mean additional years of healthy life that an older adult of specified age, sex, and health status would experience. We found, for example, that 65-year-old women in excellent health can expect 16.8 years of healthy life in the future, compared to only 8.5 years for women in poor health. We also provide estimates of discounted years of healthy life and future life expectancy. These estimates may be used to extend the effective length of the study period in cost-effectiveness studies, to examine the impact of chronic diseases or risk factors on years of healthy life, or to investigate the relationship of years of life to years of healthy life. Several applications are described. j clin epidemiol 51;4: 343-353, 1998.
INTRODUCTION
prove health status and increase the years of healthy life in the treatment group. One study goal was to determine the Clinical trials increasingly include sequential measures of incremental cost per year of healthy life gained, by measurhealth-related quality of life, in addition to the more tradiing health status at baseline, year 2, and year 4, and using tional assessments of morbidity and mortality. These data these values to estimate the area under the health status are often summarized by plotting the health status values curve (YHL) for the treatment and control groups. The difover time and calculating the area under the curve. For cerference in mean YHL for the two groups is the average years tain health status instruments, the area under the curve can of healthy life gained by those in the treatment group. The be interpreted as years of healthy life (YHL), a measure of cost of the preventive services package was also measured. health outcome that integrates quality of life and duration
The AHF study followed subjects for only four years, rather of survival [1] . This quantity is a variant of quality-adjusted than until all subjects had died, even though health promolife years (QALY). Measures such as YHL provide an estition was expected to confer lifelong benefits. The following mate of effectiveness for cost-effectiveness analyses. For this work is an effort to provide long-term estimates of the years reason, they have been used with increasing frequency in of healthy life that participants would have experienced beclinical trials and program evaluations that measure both yond the study period, which can be used in AHF and other the cost and outcomes of treatments [2] [3] [4] [5] [6] [7] [8] .
studies. One example of such a trial is the A Healthy Future (AHF) study, which evaluated the cost and effectiveness of providing and reimbursing preventive health services to METHODS Medicare patients [2] . The intervention was expected to im-A person's health state at a particular time can be defined by that person's age, sex, and health status (excellent, very to another in two years. For example, we estimated the probability that men currently aged 65 and in excellent YHL ϭ AREA ϭ
(1) health would be in poor health two years later at age 67. We then used these transition probabilities sequentially to estimate the probability of being in various health states For example, in the AHF trial, which measured health at many years later. We summarized the expected years spent baseline and at years 2 and 4, K ϭ 2 and t K ϭ 4, and the in each health state to give an estimate of future years of estimated area is h 0 ϩ h 2 ϩ 2h 1 . healthy life (YHL) . In this section we discuss health status measures, calculation of the area under the curve, the data Data sets, estimation of transition probabilities, and estimation of years of healthy life. Since the calculation methods are someData for estimating transition probabilities were taken from two large prospective studies of older adults (ages 65-100). what involved, the reader may prefer to read the Results section first, returning to this section for additional detail.
The first data set was from the AHF study [2], described above. Approximately 5000 randomly chosen Medicare enrollees in an HMO were offered participation in the ranHealth Status and Years of Healthy Life domized study of health promotion services, with about a 50% response [18] . This resulted in 2524 people who were The measure of health status that was available in both data sets was self-reported health (Is your health excellent, very randomized to either treatment or control and followed for four years, with health status ascertained at years 0.0, 2.0, good, good, fair, or poor?) (EVGFP). EVGFP, which is also referred to as self-rated health status, is a simple but welland 4.0, using mailed surveys. Since the study ultimately showed no treatment group difference, both groups are used known measure which has been studied in detail [9, 10] . It has been found to be predictive of future health events in for this exercise. The second and larger data set comes from the Cardiovasmany studies, as shown in a recent review [11] . Because we are examining health status over time, we added a sixth cular Health Study (CHS) (see Appendix A for participating institutions and principal staff), a population-based lonhealth state, death.
To measure years of healthy life, the area under the plot gitudinal study of 5201 adults 65 years of age and older designed to identify factors related to the occurrence of corof average health by time must have meaning. For most of the YHL calculations, we recoded EVGFP as ''Healthy (yes/ onary heart disease and stroke [19] . CHS subjects were recruited from a random sample of the HCFA Medicare eligino)'' where excellent, very good, and good health are coded 1.0, and fair or poor health and death are set to 0 [12] . We bility lists in four communities in the United States [20] . Those persons eligible to participate were 65 years or older made the split between good and fair because it is common to summarize EVGFP as the percent of people in fair or poor at the time of the recruitment, were not institutionalized, and were expected to remain in the area for the next three health status (e.g., [13] ). Many studies have shown that people in ''good'' health have lower mortality than those in years. Persons who used wheelchairs at home or were receiving hospice treatment, radiation therapy, or chemotherapy ''fair '' health (e.g., [14, 15] ). The average value of ''Healthy'' for a group is the proportion of people in that group who for cancer at baseline were excluded. Six-year vital status is known for all subjects. At baseline and every six months are in excellent, very good, or good health. The area under the plot of Healthy by time is the mean number of personthereafter, subjects were asked to rate their health. The year 0.0 (baseline) health data came from a home interview, years spent in excellent, very good, or good health, which is a measure of YHL. A different coding method which uses years 1.0, 3.0, 4.0, 5.0, and 6.0 from a mailed survey, and years 0.5, 1.5, 2.5, 3.5, 4.5, and 5.5 from a telephone intera separate value for each of the six health states is discussed below.
view. Health status was not ascertained at year 2.0. A third data set, also from the Cardiovascular Health Study, was a sample of 654 African Americans drawn from Area Under the Curve (YHL) the same geographic areas, using the same criteria, and followed (to date) for four years. These data were used here to Suppose that health status is measured at time 0 and at K later times, covering the time period from time t 0 to t K . If test whether estimates of years of healthy life based on the larger data sets could be used in a very different population. the proportion of people who are healthy at each time is plotted against time, the area under that curve is the averTo avoid bias from excluding people who were missing some health status measures, we interpolated values for the age person-years of healthy life that the population experienced. In our notation, at times t 0 , t 1 , . . . , t K , one meamissing observations whenever there was a valid measurement before and after the missing observation (about 4% sures the proportion of the population that is healthy, h 0 , h 1 , . . . , h K . If the measurements occur at regular intervals, of all the data). In addition, year 2.0 was interpolated for all CHS participants. After linear interpolation we added and t 0 ϭ 0, the simplest estimate of the area under the curve (YHL) comes from a trapezoidal or ''connect the dots'' strata small amount of random error and then rounded to the nearest health category. In the CHS data, after interpolaegy [16, 17] , with tion, 97% of all persons had complete data. In AHF, 95% then calculated using Eq. (1). Rogers et al.
[22] used a related method to estimate active life expectancy. were complete after interpolation. We decided to include CHS data from years 6.5 and 7, even though they were not Results were validated by comparing observed to estimated YHL for four years in three data sets, one of which complete, in order to obtain additional observations for the oldest subjects.
was not used to generate the transition probabilities. In addition, we compared lifetime expected years of life and years of healthy life to estimates calculated from U.S. life tables Estimating Transition Probabilities [23] and national estimates of health status [13] . Because the national data do not permit one to calculate life expecWe first estimated the probability of transition from one health state to another, two years in the future, based on a tancy as a function of baseline health, we compared the national estimates to a weighted sum of our estimated life person's initial age, sex, and health status (e.g., the probability that 65-year-old men now in excellent health will be in expectancies and healthy life expectancies. We used the estimated YHL to reexamine the results of poor health two years later). The two-year interval was chosen in part because it was used in the AHF study, and also the AHF study mentioned above, to look at the effect of a chronic disease on YHL, and to examine the relationship because some change in health could be expected in two years. We calculated transition probabilities for each initial of years of life to years of healthy life. age, sex, and health state, using all available two-year transitions. For example, in the AHF study, 65-year-old men had Healthy Life-Table Estimates health measures at ages 65, 67, and 69. We used their health
From an abridged U.S. life table [23] and national data on state transitions from age 65 to age 67, and also their transithe percent of people in excellent, very good, or good health tions from age 67 to age 69. In CHS, health status was meaby age and sex [13] we constructed a healthy life table [1, 24] . sured at six-month intervals, allowing, for example, use of
The healthy life table is similar to an ordinary life table data at year 1.5 to predict health at year 3.5. Each AHF except that the number of person-years in each age category person thus contributed about two transitions, and each are multiplied by the proportion of people in that age group CHS person contributed up to 11. who are healthy, before summing. It is not necessary to asWe summarized the probabilities of these transitions by sume that people's health cannot improve. The result was initial age, sex, and health status. Because some of the catethat on average men aged 65 could expect an additional gories had few observations, we also created a linear model 11.4 years of healthy life (YHL) and on average women an to predict the transition probabilities. This was done sepaadditional 13.9 YHL. These national numbers were comrately for each initial health state, using six-group discrimipared to the numbers we generated, as a form of validation. nant analysis to estimate the probability of being in each of the six health states two years later, as a function of a person's initial sex, log age, and squared log of age. The FINDINGS model was chosen by inspection of plots of the data. This analysis yielded fitted estimates of the transition probabili-
The primary goal of this article is to calculate estimates of ties, out to age 103.
years of healthy life. Tables 1-5 present a sample of interim Because some cells had large numbers and some had small results from the estimation process. numbers, we created a ''blended'' estimate of the transition probabilities, designed to let the large cells be selfTransition Probabilities representing but the smaller cells be more model dependent. For cells with more than 500 observations, the blended The CHS and AHF data sets together yielded 56,731 transitions. Table 1 shows the distribution of the 23,702 observatransition probability estimate was 0.9⋅(Observed transition probability) ϩ 0.1⋅(Fitted transition probability), or tions for men, by initial age and health. For example, only 16 transitions involved men aged 65-66 in poor initial 0.9⋅O ϩ 0.1⋅F; for 300-500 observations, the blended estimate was 0.75⋅O ϩ 0.25⋅F; and for cells with fewer than health. The total sample size is large, but many cells are small or empty, especially for the youngest and oldest ages, 300 observations the estimate was (n/400)⋅O ϩ (1 Ϫ n/ 400)⋅F. For example, the blended estimate for a cell with and for excellent and poor health. Similar data were created for women (not shown). 40 observations would be 0.10⋅O ϩ 0.90⋅F.
It is necessary to have probabilities for every cell in order to calculate total future years of healthy life. For this reason,
Years of Healthy Life
we performed the six-group discriminant analysis described above, to provide ''fitted'' probability estimates which were We used the blended transition probabilities to estimate health in the future, using standard probability calculations then blended with the observed probabilities. For example, of the 16 men aged 65 and in poor health, 12.5% were dead [21] , as illustrated below. We modeled transition as a nonhomogeneous Markov process, since transition probabilities two years later, but the fitted estimate was 21.4% (not shown). The blended transition probability, described above, change with age. Expected future years of healthy life were is calculated as (16/400)⋅(12.5) ϩ (384/400)⋅(21.4) ϭ men initially aged 65-66 and in excellent health, as shown on the first line of the table. According to the transi-21.07%. For 67-68-year-old men in good health, there were 643 cases in the data set, and the blended probabilities of tion probabilities in the fifth line of Table 2 , we would expect that about 0.89% or 890 men would be dead two death in two years are 0.9⋅(5.75) ϩ 0.1⋅(3.65) ϭ 5.54%. The blended transition probabilities are shown in Table 2 , years later at age 67, that 510 would be in poor health, and so on. This distribution is shown on the second line for men aged 65-68. Similar tables were calculated for the other age groups and for women (not shown). Note that a of Table 3 .
To estimate the distribution of health states at age 69, substantial number of people improved in health over time; for example, 18% of those aged 65-66 who were initially we apply the transition probabilities for age 67-68 (shown in the bottom half of Table 2 ) to each of the new groups in poor health were in good health two years later, possibly because they had acute illness in the first period.
of people. For example, the expected number of deaths by age 69 is the 890 already dead plus 0.2553 times the 510 in poor health at age 67, ϩ 0.1063⋅2500 ϩ 0.0554⋅13,750 Estimating Future Health ϩ 0.0158⋅39,050 ϩ 0.0091⋅43,290 ϭ 3059. This number is shown in the third line of Table 3 . Other values were calcuWe next used the two-year transition probabilities to estimate health further in the future. For example, Table  lated in a similar manner. Table 3 thus provides the expected health history for a 3 shows calculations for a hypothetical cohort of 100,000 hypothetical cohort of 100,000 men in excellent health at pectancy) for men in excellent health at age 65. The area under the lower curve is the projected years of healthy life. age 65. Note that, at age 95, almost all of the men are dead, which means that the lack of data at the oldest ages did
The area between the two curves is the average years of life spent in fair or poor health. not have a large influence on the estimates. For men in excellent health at age 85 (not shown), we also found that most had died well before age 103. Similar health histories Validation were computed for each initial age-sex-health status combi-
The YHL estimates are a complicated function of paramenation (not shown).
ters estimated from data. The validity of the estimates was The last two columns of Table 3 show summary measures examined by comparing predicted years of healthy life in for the health distributions. The first is the percent of people four years against observed four-year YHL in three different alive at this age, and the second is the percent who are data sets. We also compared lifetime years of life and years ''healthy'' (in excellent, very good, or good health). Observed versus Estimated YHL in the Next Four Years the three databases were assigned an ''expected'' YHL value, to be compared with their actual or observed YHL. For exWe used available longitudinal data to calculate the observed YHL for people for a four-year period, in three differample, all men aged 65 and in excellent health at baseline were assigned 3.81 estimated YHL. ent data sets, using Eq. (1). The data sets were the AHF and CHS data, plus the cohort of African Americans.
The top part of Table 4 shows the average observed and estimated YHL for the CHS data. Overall, mean observed We then estimated the years of healthy life that subjects would be expected to have in the next four years, based on YHL was 2.98 years, and mean estimated YHL was 2.87 years, a difference of only 0.11 years of a possible total of their baseline age, sex, and health status, using data from Table 3 and similar tables. For example, for men aged 65 4. Data are also tabled by initial age, sex, and health. Observed YHL varied with age and initial health status, and in excellent health, Table 3 shows that 100% were healthy at year 0, 96.1% were healthy at year 2.0, and 89.2% were the estimates tracked that variation well. The maximum discrepancy (for those aged 80ϩ or those initially in fair healthy at year 4.0. Using Eq. (1), the estimated area under the four-year curve is 1.0 ϩ 0.892 ϩ 2⋅0.961 ϭ 3.81 years health) is only about three months (0.26 years). This may not be strong evidence of validity, however, since most of of healthy life. These calculations were repeated for all age, sex, and initial health status combinations, and people in the data came from CHS study to begin with. The middle of Table 4 shows similar information from few observations for ages over 85, as shown in Table 1 ; the estimates for the oldest group are based substantially on a stathe AHF data set, which contributed only about 10% of the transition probability data. Mean observed and extistical model that cannot be verified with present data. National life tables are available, but not by health status pected YHL were both 3.03 years. The agreement is quite good, with the greatest difference again being about three [23] . To compare our estimates with national figures, we calculated a weighted mean of the life expectancy values months for those over 80 or in fair health.
The bottom of Table 4 shows similar data for 654 African in Table 5 for people aged 65, weighting by the estimated proportion of people nationally in each age and health staAmericans whose data were not used at all in creating the transition probabilities. They were less healthy than the tus category. For women aged 65, those percentages were 7.1% poor, 17.9% fair, 34.9% good, 21.9% very good, and other two cohorts. Their overall observed YHL was only 2.45 years out of four years, but it was estimated almost ex-17.7% excellent; for men, the corresponding percentages were 8.2%, 17.6%, 33.8%, 21.6%, and 18.6% [13] . We then actly by the model (discrepancies are due to rounding). As in the other two data sets, the fit is quite good overall and compared this weighted mean life expectancy to the U.S. life expectancy for whites in 1989 [23] . For women aged 65, by age and sex. The greatest discrepancy is for people in fair health, a discrepancy of 0.30 years.
we 
years difference). Our estimates are thus a Lifetime Future Years of Life (YOL)-Life Expectancy
little higher than those from national data. For other initial As another validity check, we projected years of life (life exages, the estimates were usually within about a year of the pectancy) out to age 103, and compared it to life table data national numbers. Since the national health status data from the United States. We calculated YOL in our data by were sample estimates, and included only the civilian noncomputing the area under the top curve in Figure 1 using the institutionalized population, they contain some measure-''% Alive'' column in Table 3 , and Eq. (1). We then fit a ment error. The agreement seems satisfactory, and suggests quadratic equation to predict YOL from age, for each sex and that our health-specific estimates are also satisfactory. initial health status, and used the equations to estimate life expectancies at five-year intervals, to match the national Lifetime Future YHL data. The predicted life expectancies are shown in Table 5 , categorized by initial age, sex, and health status. For example,
We next estimated future years of healthy life out to age 103. For example, for men age 65 and in excellent health, the average woman aged 65 in excellent health would have 21.5 more years of life, compared with men in poor health we applied Eq. (1) to the last column in Table 3 , to get the area under the lower curve in Figure 1 . The estimates are who would have 11.7 years of life. We do not show estimates for people older than age 85 because there were relatively shown in Table 6 by initial age, sex, and health status. For example, men aged 65 and in excellent health can expect the individual values, such as those in Table 3 , must be known. 14.7 future years of healthy life. The YHL estimates vary considerably by age, sex, and initial health status.
Our healthy life table calculations, based on national Alternative Coding of EVGFP data, suggested 11.4 YHL for men aged 65 (not available
In the above, we coded the six health categories as dead/ by initial health status). The weighted mean of our estipoor/fair ϭ 0, and good/very good/excellent ϭ 1. Another mates for men aged 65 is 12.3 years. For women, the healthy summary weighting which assigns a unique scale value to life table gave 13.9 years, while our estimate for U.S. women each health state has been suggested (death ϭ 0, poor ϭ aged 65 was 14.6 years. For men and women, the national 0.19, fair ϭ 0.35, good ϭ 0.76, very good ϭ 0.93, and exceldata agree with our projections to within a year, which is lent ϭ 0.96) [12] . YHL calculated using those weights is satisfactory.
shown in Table 8 . The results are similar to those of Table  6 , although YHL is somewhat lower for the healthiest peoDiscounted YHL ple and somewhat higher for those who were initially In cost-effectiveness analyses, it is common to discount sickest. both the benefits and the costs at 3% per year [25] . Table  7 shows estimated YHL discounted at 3% per year, using APPLICATIONS the midpoint of the age interval. That is, the YHL for the Clinical Trial of Cost Effectiveness first two years is multiplied by 0.97, the YHL for the next two years by 0.97 3 , the following by 0.97
5
, and so on, before The AHF trial, described above, was designed to test the hypothesis that provision of reimbursed health promotion summing. Discounting makes a large difference. For example, for 65-year-old women in poor health, 8.5 YHL are and disease prevention services to older adults would increase their future years of healthy life. Unfortunately, the expected (Table 6 ) but the discounted value is only 4.3 years, or about half as large. The shrinkage is largest for the study lasted only four years, and no YHL benefits were found, in part because there were slightly more deaths in youngest ages, since relatively more of their future years of healthy life will be far in the future. The shrinkage is about the treatment group than in the control group. However, the treatment group also had more people in excellent the same for men and women. Note that the discounted values cannot be calculated directly from Table 6 , because health than the control group at the end of four years. It was conceivable that a longer study would have found women in excellent health, the average expected years of healthy life would be (from Table 6 ) (6.3 ϩ 10.4)/2 ϭ 8.35 higher YHL in the treatment group.
To assess this possibility, and to provide the basis for cost-YHL. Such estimates should be more accurate than those based on a healthy life table, which does not take initial effectiveness studies, we used the data from Table 6 to predict YHL after the study ended. That is, we assigned an health status into account. estimate of future YHL to each person, based on the person's age-sex-health status at the end of the trial. (People dead Years of Life versus Years of Healthy Life at the end of the trial received no additional years of healthy life.) The control and treatment group had 3.06 and 3.00
These tables can also be used to study the relationship of YHL, respectively, during the four-year study. Their estiyears of life to years of healthy life, by comparing the future mated additional YHL were 6.82 and 6.68, for a total of years of life in Table 5 to the years of healthy life in Table  9 .89 YHL for controls, and 9.69 YHL for the treatment 6. For example, women age 65 and in poor health can exgroup. No significant differences were detected. Since there pect, on average, to live an additional 15.8 years, of which was no evidence of effectiveness of the treatment, even 8.5 will be years of healthy life; that is, they will spend about when projected in the future, cost/effectiveness analyses 54% of their remaining years ''healthy.'' In contrast, women were not performed.
age 65 in excellent health will on average be healthy for If we had chosen to discount costs and years of healthy 78% of their future life. life at 3%, we would have multiplied the observed YHL in the first two study years by 0.97, and in the second two years DISCUSSION by 0. The simple measure of health status used in this study is However, instead we must use Table 7 . Recall that the first routinely collected in national surveys, and is also one of two-year period in Table 7 was multiplied by 0.97; therefore, the items on the popular SF-36 health status instrument the value in Table 7 ably well for a population, and it is easy to interpret the area under the curve as the number of years that an average Effects of Cardiovascular Disease on YHL person was healthy. The alternative weighting used in Table  8 may be preferred because it distinguishes between the six The YHL tables can be used to estimate the current and different health states. The weights were chosen to reflect, future effects of a chronic problem such as cardiovascular approximately, the probability that the person would be disease (CVD). In the CHS study, prevalent CVD at basehealthy two years later [12] . The interpretation of the area line was defined as any heart disease, peripheral vascular under this curve is, however, less clear than is the area under disease, or cerebrovascular disease [26] . The 2759 subjects the ''healthy yes/no'' curve. (The weights are an estimate without CVD at baseline averaged 4.9 YHL during the first of the probability of a person being healthy in two years, six years of the study, as compared to 3.9 YHL for those based on a different data set and ignoring age and sex. If with CVD. Mean future YHL estimates (from Table 6 , the weights were each person's true probability of being matched with the person's observed age/sex/health at year healthy in two years, the area under the curve would be the 6.0) were 6.2 and 4.5 for the two groups, yielding a total of future years of healthy life starting two years in the future.) 11.1 YHL for those without CVD, and 8.4 for those with Since both coding methods provided similar YHL estimates, CVD. This method reflects the effects of CVD on both obthe choice of method does not seem important in this appliserved and future YHL. Further analysis would probably excation. amine the effects of age, gender, and other comorbidities. Such an approach could also be used to examine the effect of various risk factors on future years of healthy life. Data
Both of the data sets from which the probabilities were Predicting YHL for a Group estimated had some positive selection bias, since very sick people were not eligible for CHS, and AHF consisted of It may be of interest to predict the future years of life or years of healthy life for a particular group, such as members people who volunteered for a health promotion program. Such selection bias is not necessarily a problem. CHS and of a retirement plan. If the group consisted, for example, of 100 65-year-old men in poor health and 100 75-year-old AHF may have ''too few'' sick people, but the analyses for CONCLUSION this article require only that the people who are in poor health be representative of other people in poor health. FurWe created estimates of future years of healthy life for older ther, the bulk of the transition data come from later in the adults, based only on their initial age, sex, and health status. study, when the selection effects will have attenuated. The
The estimates validated reasonably well. They should be good validation results with national data and for the Afriuseful in other studies involving years of healthy life where can American cohort suggest that the estimates in Tables people are not followed until death. 5-7 should be appropriate in other settings, even for sicker populations. estimates on only 1300 transitions, versus the 56,731 that 377-381. were available here. The Markov assumption that a person's
